IMPACCT: exploratory study of a community pharmacy pain medicines consultation for patients with cancer pain

niversity of Bradford0 个研究点目标入组 45 人开始时间: 2015年1月21日最近更新: 2022年9月26日

适应症

试验速览

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30963448 medicines optimisation results (added 24/06/2019) 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29479766 patient interview results (added 24/06/2019)

•1. Aged 16 or over
•2. Have advanced cancer and pain
•3. Been receiving strong opiods for 2 weeks or more (morphine, fentanyl, buprenorphine, diamorphine, hydromorphone, methadone or oxycodone)
•4. Have a good level of spoken and written English (we do not have the resources to employ an interpreter at this time)
•5. Have the capacity to provide informed consent to participate
•6. Be deemed well enough to take part by their healthcare provider
•Stage 3 - as well as the criteria for stage 1 the participants should:
•1. Regularly use the pharmacies participating in the study it is not feasible to train all the local pharmacists to provide this service at this point but may be an option for future role out.
•Patients with advanced cancer will be defined as:
•Those with metastatic cancer (histological, cytological or radiological evidence) AND/OR those receiving anti-cancer therapy with palliative intent
•Patients with pain will be defined as:
•Those receiving strong opiod analgesic treatment for cancer symptom-related pain AND/OR those receiving analgesics for treatment of cancer therapy-related pain

•Stage 1 and 3:
•1. Are unconscious or confused
•2. Are, in the opinion of the clinician, unable to understand and complete the interview or questionnaires (due to cognitive impairment for example)
•3. Are unwilling to provide informed consent
•4. We are not looking to recruit patients in the last days of life so we will exclude those who have received anticipatory medicines in readiness for this
•Stage 3 only:
•1. They do not use one of the participating pharmacies (although these patients may be included at a later date if the study is expanded)
•2. Patients who are deemed ethically inappropriate to approach for example where death is imminent.

发起方

niversity of Bradford